http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-201000052-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
filingDate 2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff3362443cd544befa56aa7f3530f238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f373319cb3162ec4a873156150a9387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7906fbedf8c3f094023d8969a554fad
publicationDate 2015-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-201000052-A
titleOfInvention PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF ACEMETACINE, METOCARBAMOL AND DIACEREINE, USEFUL IN THE TREATMENT OF Rheumatoid ARTHRITIS AND RELATED DISEASES.
abstract THE PRESENT INVENTION REFERS TO A COMPOSITION PHARMACEUTICAL COMPOSITION OF A NON-STEROID ANTI-INFLAMMATORY, KNOWN AS: ACEMETACINE, A RELAXING MUSCULAR OF CENTRAL ACTION, KNOWN AS: METACARBAMOL AND A SELECTIVE DIVESTER OF AS A DIFFERENT ONE: PHARMACEUTICALLY ACCEPTABLE, WHICH ARE FORMULATED IN A SINGLE DOSE UNIT TO BE ADMINISTERED BY ORAL, SAME THAT IS USED FOR THE CONTROL AND TREATMENT OF RHEUMAID ARTHRITIS AND RELATED DISEASES, WHICH PROVIDES A MAXIMUM RAPID AWARENESS OF THE THERAPEUTIC EFFECT IN LESS TIME, AS WELL AS A REDUCTION OF INFLAMMATION, PAIN AND MODIFICATION OF THE DISEASE COURSE, DECREASING THE RISK OF SIDE EFFECTS MANIFESTING.
priorityDate 2007-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4107

Total number of triples: 29.